Methylphenidate Hydrochloride
Methylphenidate Hydrochloride
1 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Methylphenidate Hydrochloride
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Actavis Pharma, Inc. | unknown | 4 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Methylphenidate Hydrochloride Tablet, Extended Release — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Psychiatry.
CGMP deviations: Product bottle may be absent of desiccant. — Recalling firm: Teva Pharmaceuticals USA — USA Nationwide
CGMP deviations: Product bottle may be absent of desiccant. — Recalling firm: Teva Pharmaceuticals USA — USA Nationwide